Results 1 -
10
of
11
for
Quizartinib
- Quizartinib is used with other chemotherapy drugs to treat a certain type of acute myeloid leukemia (AML; ... type of cancer of the white blood cells). Quizartinib is in a class of medications called kinase ...
- Find out what's new in current leukemia research including progress on targeted therapies and immunotherapies, and NCI programs and clinical trials. ... Leukemia/ ...
- Acute Myeloid Leukemia/Start Here ... Acute Myeloid Leukemia ... Treatment options for adult acute myeloid leukemia (AML) include chemotherapy, radiation therapy, ...
- Acute Myeloid Leukemia/Diagnosis and Tests ... Acute Myeloid Leukemia ... National Cancer Institute ... Treatment options for adult acute myeloid leukemia (AML) include ...
- Acute Myeloid Leukemia/Treatments and Therapies ... Acute Myeloid Leukemia ... National Cancer Institute ... Treatment options for adult acute myeloid leukemia (AML) ...
- Cancer/Treatments and Therapies ... Cancer ... Cancer Chemotherapy/Start Here ... Cancer Chemotherapy ... National Cancer Institute ... From the National Institutes of Health ... List ...
- Leukemia/Treatments and Therapies ... Leukemia ... National Cancer Institute ... From the National Institutes of Health ... This page lists cancer drugs approved by the FDA ...
- LiverTox: Clinical and Research Information on Drug-Induced Liver Injury
(National Library of Medicine) (National Institute of Diabetes and Digestive and Kidney Diseases)
Liver Diseases/Statistics and Research ... Liver Diseases ... Medicines/Statistics and Research ... Medicines ... LiverTox® provides regularly updated, unbiased and easily ... - Breastfeeding/Statistics and Research ... Breastfeeding ... National Library of Medicine ... The LactMed® database contains information on drugs and other chemicals ...
- What's New in Acute Myeloid Leukemia (AML) Research? (American Cancer Society)Acute Myeloid Leukemia/Statistics and Research ... Acute Myeloid Leukemia ... American Cancer Society ... Study of causes, prevention, and treatment of AML is ongoing ...